US Patent Issued to Nanjing Noratech Pharmaceuticals on Oct. 7 for "Aripiprazole injectable suspension formulation having prolonged shelf life" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,887, issued on Oct. 7, was assigned to Nanjing Noratech Pharmaceuticals Co. LTD (Nanjing, China).

"Aripiprazole injectable suspension formulation having prolonged shelf life" was invented by Yunzhe Sun (Jiangsu Province Nanjing, China), Qi Peng (Jiangsu Province Nanjing, China), Cheng-Gang Lin (Jiangsu Province Nanjing, China), Li Gui (Jiangsu Province Nanjing, China), Zhihui Liu (Jiangsu Province Nanjing, China) and Fei Liu (Jiangsu Province Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulati...